$ cat ./records/gates-funded-project-releases-genetically-modified-mosquitoes-in--2019.txt
Gates-Funded Project Releases Genetically Modified Mosquitoes in Burkina Faso, Sparking Backlash
[RECORD.TXT] · cat --full
In July 2019, the Gates Foundation–backed Target Malaria consortium carried out the first release of genetically modified mosquitoes in Africa, freeing sterile male insects in a village in Burkina Faso as an early step toward 'gene drive' technology meant to crash malarial-mosquito populations. Civil-society and environmental groups opposed the project, raising concerns about informed consent, biosafety, and unknown ecological effects of altering wild populations. Target Malaria said it had obtained community agreement and that the released mosquitoes posed no gene-drive risk. Years later, citing biosafety and sovereignty concerns, Burkina Faso moved to halt the program. The episode became a flashpoint in the debate over Gates-funded genetic experiments in the developing world.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Study Ranks Bill Gates Among the Top Celebrity Carbon Emitters From Private Jets
Next →
Gates Is Repeatedly Named the World's Most Admired Man
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.